3rd Quarter - Report
WAXMAN STRATEGIES for CHRISTOPHER AND DANA REEVE FOUNDATION
Firm
Income
$5,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Support for non-profit pharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 |
Medicare/Medicaid MMM
Provisions related to Home and Community Based Services for Medicaid - monitored inclusion in COVID response legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 |
Health Issues HCR
COVID-19 response legislation:
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.